NFKB1 and allergic asthma: A recent study has indicated that in response to an ovalbumin challenge (a well-accepted murine model of allergic asthma), mice treated with arsenic trioxide demonstrated significant immune suppression indicated by decreases in cytokine production, reduced eosinophil recruitment/migration to the lung, and diminished NFκB activation (Zhou et al. 2006).